You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recombinant Human Hyaluronidase

Showing 76 - 100 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Systemic Lupus Erythematosus Trial in Changchun (IL-2)

Completed
  • Systemic Lupus Erythematosus
  • Changchun, Changchun/Jilin, China
    Sirui Yang
Aug 16, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Achondroplasia Trial in Shanghai (Recombinant human growth hormone)

Not yet recruiting
  • Achondroplasia
  • Recombinant human growth hormone
  • Shanghai, Shanghai, China
    Children's Hospital of Fudan University
Apr 25, 2022

Chronic Prostatitis Trial (Interferon gamma human recombinant (IFN-G))

Completed
  • Chronic Prostatitis
  • Interferon gamma human recombinant (IFN-G)
  • (no location specified)
May 12, 2022

Idiopathic CD4 T Cell Lymphocytopenia Trial run by the NIAID (Gardasil 9)

Recruiting
  • Idiopathic CD4 T Cell Lymphocytopenia
  • Gardasil 9
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 10, 2023

Metastatic Non Small Cell Lung Cancer Trial in Worldwide (Lazertinib, Amivantamab Subcutaneous and Co-Formulated with

Recruiting
  • Advanced or Metastatic Non-small Cell Lung Cancer
  • Duarte, California
  • +208 more
Jan 31, 2023

Osteoporosis, Spinal Fusion Trial (RhBMP-2)

Not yet recruiting
  • Osteoporosis
  • Spinal Fusion
  • (no location specified)
Jun 20, 2023

Pneumonia, Ventilator-Associated Trial in France (Interferon gamma, Placebo)

Not yet recruiting
  • Pneumonia, Ventilator-Associated
  • Interferon gamma
  • Placebo
  • Lyon, France
  • +6 more
May 2, 2023

Chronic Kidney Disease (CKD) Trial in Jakarta (Recombinant Human Erythropoietin Alpha)

Completed
  • Chronic Kidney Disease (CKD)
  • Recombinant Human Erythropoietin Alpha
  • Jakarta, Indonesia
    Gatot Soebroto Army Hospital
Jul 12, 2022

Group 3 Pulmonary Hypertension Trial (recombinant human brain natriuretic peptide, Placebo)

Not yet recruiting
  • Group 3 Pulmonary Hypertension
  • recombinant human brain natriuretic peptide
  • Placebo
  • (no location specified)
Jan 30, 2023

Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)

Recruiting
  • Pemphigus Vulgaris
  • Pemphigus Foliaceus
  • efgartigimod PH20 SC
  • +2 more
  • Birmingham, Alabama
  • +130 more
Dec 22, 2022

Cervical Intraepithelial Neoplasia, Cervical Cancer, Vaginal Intraepithelial Neoplasia Trial in Dongtai (Recombinant Human

Completed
  • Cervical Intraepithelial Neoplasia
  • +4 more
  • Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) / Cecolin®
  • Dongtai, Jiangsu, China
    Dongtai City Center for Disease Control and Prevention Dongtai,
Jun 22, 2022

Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)

Not yet recruiting
  • Lymphoma
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Apr 18, 2023

Ingaron in Volunteers for the Prevention of COVID-19

Completed
  • COVID-19 Respiratory Infection
  • Interferon gamma human recombinant (IFN-G)
  • Moscow, Russian Federation
    City Clinical Hospital named after M.E. Zhadkevich Moscow City H
May 20, 2022

Recombinant Human Growth Hormone on ADHD Characteristics in

Recruiting
  • Growth Hormone Deficiency
  • +2 more
  • Questionnaires
  • Zrifin, Israel
    Assaf Haroffeh Medical center
Aug 7, 2022

Recombinant Human Erythropoietin in VLBW and ELBW Infants

Not yet recruiting
  • Erythropoietin; Infant; Surveys and Questionnaires
  • not use of any intervention
  • (no location specified)
May 11, 2022

Healthy Trial (Experimental Erythropoietin subcutaneous injection single dose of 4,000 IU, Active comparator Erythropoietin

Not yet recruiting
  • Healthy
  • Experimental Erythropoietin subcutaneous injection single dose of 4,000 IU
  • Active comparator Erythropoietin Eprex® subcutaneous injection single dose of 4,000 IU
  • (no location specified)
Apr 8, 2022

Hemophilia A Trial in China (ADVATE, FRSW107)

Recruiting
  • Hemophilia A
  • Beijing, Beijing, China
  • +5 more
Jun 27, 2022

Severe Hemophilia A Trial in China (ADVATE, FRSW117)

Completed
  • Severe Hemophilia A
  • Guangzhou, Guangzhou, China
  • +3 more
Jun 27, 2022

In Vitro Maturation of Oocytes Trial in Brussels (rhCG= Ovitrelle®, 250g/0.5ml = 26000IU/ml, Merck-Serono, rFSH = Gonal F®,

Recruiting
  • In Vitro Maturation of Oocytes
  • rhCG= Ovitrelle®, 250g/0.5ml = 26000IU/ml, Merck-Serono
  • rFSH = Gonal F®, 300IU/0.5ml, Merck-Serono
  • Brussels, Belgium
    UZ Brussel
Nov 4, 2022

Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for

Not yet recruiting
  • Primary Hepatocellular Carcinoma
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • camrelizumab for Injection
  • (no location specified)
Nov 13, 2023

Non Small Cell Lung Cancer, Endostatin Trial in Guangzhou (Endostatin)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Endostatin
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital and Institute of Guangzhou Medical Un
Jul 4, 2022

Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

Recruiting
  • Untreated Advanced Non-small Cell Lung Cancer
  • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Nov 13, 2023

Human Papillomavirus Infection Trial in United States (Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant

Active, not recruiting
  • Human Papillomavirus Infection
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +5 more
Jan 26, 2023

Cervical Carcinoma, Human Papillomavirus Infection Trial in Liberia (Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis

Enrolling by invitation
  • Cervical Carcinoma
  • Human Papillomavirus Infection
  • Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
  • +3 more
  • Liberia, Guanacaste, Costa Rica
    Agencia Costarricense de Investigaciones Biomédicas - Fundación
Aug 11, 2022